Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Transtema in conjunction with a rights issue
Mandate

Vinge has advised Transtema in conjunction with a rights issue

October 09, 2018 Capital Markets and Public M&A

Vinge has advised Transtema in connection with a rights issue.

The issue proceeds of approximately MSEK 78 will be used for a part financing in the acquisition of Ericsson Local Services as well as to facilitate future growth efforts.

The prospectus was approved by the Swedish Financial Supervisory Authority on 14 September 2018 and the subscription period expired on 1 October 2018.

Vinge’s team primarily consisted of Anders Strid, Wibeke Sorling, Natalie Bäck and corporate assistant Camilla Andersson.
 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025